Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene expression profiling based identification of CKS1B as a potential therapeutic target in multiple myeloma

Gene expression profiling based identification of CKS1B as a potential therapeutic target in multiple myeloma

US Patent 7935679 · Granted May 3, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GEP5 model for multiple myeloma2024
Compositions and methods for cancer therapy2022
GEP5 model for multiple myeloma2020
Use of gene expression profiling to predict survival in cancer patient2020
Use of gene expression profiling to predict survival in cancer patient2020
Use of gene expression profiling to predict survival in cancer patient2020
Diagnosis, prognosis and identification of potential therapeutic targets of mult2020
Diagnosis, prognosis and identification of potential therapeutic targets of mult2020
Diagnosis, prognosis and identification of potential therapeutic targets of mult2020
Compositions and methods for cancer therapy2018
GEP5 model for multiple myeloma2017
Diagnosis, prognosis and identification of potential therapeutic targets of mult2017